Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Aug 1997, 1924-1930, Vol 35, No. 8
B Avidor, Y Kletter, S Abulafia, Y Golan, M Ephros and M Giladi
Amplification of Bartonella henselae DNA has been proposed as a diagnostic
test for cat scratch disease (CSD). The sensitivities of the following
three PCR assays were compared. PCR/rRNA with universal primers amplifies
part of the 16S rRNA gene, followed by hybridization with a specific B.
henselae probe; PCR/CS and PCR/HSP amplify portions of the gltA and the
htrA genes, respectively, each followed by restriction fragment length
polymorphism analysis. The threshold of detection of B. henselae DNA in pus
was 10(-4), 10(-3), and 10(-2) ng for PCR/rRNA, PCR/CS, and PCR/HSP,
respectively. By these three assays, B. henselae DNA was detected in 100,
94, and 69% of 32 pus and lymph node specimens from CSD patients,
respectively. The similar sensitivities of the PCR/rRNA and the PCR/CS
assays for detecting B. henselae DNA in clinical specimens are in contrast
to the 10-fold difference in sensitivities in favor of PCR/rRNA
demonstrated with purified B. henselae DNA in sterile pus, suggesting that
in the majority of cases, the bacterial load in clinical specimens is large
enough to be identified by the PCR/CS assay. A two-step approach is
suggested to achieve maximal sensitivity for detecting B. henselae in
clinical specimens: initial testing by PCR/CS (which does not require
hybridization), followed by PCR/rRNA with PCR/CS-negative specimens when
CSD is strongly suspected.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Molecular diagnosis of cat scratch disease: a two-step approach
The Bernard Pridan Laboratory for Molecular Biology of Infectious Diseases, Ichilov Hospital, Tel-Aviv Sourasky Medical Center, Israel.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|